The Times Of Bengal
For You Forever Yours
Open Channels FM: AI Sidekick Features for WooCommerce Merchants
Co-host Katie Keith asks if WooCommerce will ever get a built-in AI assistant like Shopify’s Sidekick. James LePage explains that…
Read More
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
Company’s Chief Movement Officer, Arnold Schwarzenegger,Will Be Presidential Guest Speaker WARSAW, Ind., Feb. 25, 2026 /PRNewswire/ — Zimmer Biomet Holdings,…
Read More
EF Ultimate Break Announces Camp Ultimate Experience in Switzerland for Adults
GenZ is chasing nostalgia everywhere — So EF Ultimate Break built them a summer camp experience in the Alps, including…
Read More
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
WASHINGTON, Feb. 25, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug…
Read More
TheSportExchange Announces Intent to Pursue NASDAQ Direct Listing
Performance-linked digital asset marketplace targeting H2 2026 listing; public launch scheduled for May 1, 2026 NEW YORK, Feb. 25, 2026…
Read More
Protein Pop Launches Protein Pop Plus at Costco Nationwide
The brand expands its Protein Pop line with a carbonated, clear protein beverage delivering 30 grams of protein per can…
Read More
Boehringer Ingelheim India Appoints Meenal Gauri as Managing Director
Business Wire India Boehringer Ingelheim today announced that Meenal Gauri has been appointed as Managing Director India, effective 12 January…
Read More
Garmin releases annual inReach SOS message report
Report shows an increase in SOS messages from around the world during a variety of activities in 2025 OLATHE, Kan.,…
Read More
REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
ROCKVILLE, Md., Feb. 25, 2026 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call…
Read More
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH, Feb. 25, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a…
Read More
